Register for ASTCT’s 4th International Conference on Toxicities of Transplantation and Cellular Therapies
Correction of undesirable trends in clinical outcomes is an important aspect of FACT Standards and is supported by the FACT Clinical Outcomes Improvement Committee. We are appreciative of a conference that is hosted by ASTCT to educate transplant and cell therapy programs on how to manage the toxicities of these therapies.
Registration is now open for the 4th International Conference on Toxicities of Transplantation and Cellular Therapies, which will take place November 15-16, 2024 in Philadelphia. The program will include a wide range of pre-clinical, translational and clinical topics through five main sessions. Offered in-person and virtually, this conference is ideal for physicians, advanced practice providers and nurses involved in HCT or immune effector cell therapies.
The agenda includes:
- The Expanding Scope of Toxicities after Transplantation and Cellular and Gene Therapies
- Optimizing Host Resilience
- Treating Older Transplantation and Cellular Therapy Recipients
- Promises and Pitfalls of Emerging Technologies
- Toxicities of Cellular Therapies for Solid Organ Malignancies
